Skip to main content
. 2023 Mar 30;2023(3):CD001233. doi: 10.1002/14651858.CD001233.pub4

Glagoleva 1999.

Study characteristics
Methods RCT. No details were given on the method for concealment of the allocation.
Participants BS < 5. Women with a past history of CS were excluded.
Interventions Dilapan (4 tents) removed after 12 hours (27 women).
PGE2 intracervical gel 0.5 mg (1‐2 doses) (26 women).
Outcomes CS.
Notes Abstract only
Setting: Russia
Dates of study: not reported
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Only reported women were randomly assigned.
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Not feasible due to nature of intervention
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Insufficient information to judge
Selective reporting (reporting bias) Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only, insufficient information to judge risk of bias